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Abstract: 
The crude extract of bay leaves (Laurus nobilis) grown in Egypt,  was tested for its hepatoprotective 
activity on primary cultured rat hepatocytes against paracetamol toxicity. The Neutral Red Assay was 
used to assess the hepatotoxicity of the extract and was applied with a broad range of concentrations 
(125-1000 µg/ml) on monolayer of rat hepatocytes. It revealed that the extract exerts no toxic effect 
on the monolayer hepatocytes. For the evaluation of the hepatoprotective effect; different 
concentrations were prepared, starting from 12.5 µg/mL and increasing concentration in ascending 
order by dissolving in DMSO (1% maximum concentration). For each concentration, three replicates 
were carried out, in addition to controls which were: cell control (cells only), negative control (cells + 
paracetamol) and positive control (reference) (cells + sylimarin + paracetamol).  50% mortality of the 
hepatocytes (IC50) was determined using Neutral Red Assay.  L. nobilis extract showed 
hepatoprotective activity against paracetamol toxic effect at concentration of 40 µg/ ml. The 
constitutive flavonoids of L. nobilis leaves were extensively studied and led to the separation and 
identification of 14 compounds, 10 of which   have not been previously identified in L. nobilis and 
were identified using chemical, conventional and advanced spectral techniques. 
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Introduction: 
Laurus nobilis (Lauraceae), known in English as bay laurel, sweet bay, bay tree, true laurel, or 
Grecian laurel (Brown, 1956) is an aromatic evergreen tree or large shrub with green, glossy leaves, 
native to the Mediterranean region. It has been analyzed for alkaloids (Pech and Bruneton ,1982), 
essential oils (Sellami I.H. et al.  2011, Zola et al., 1977), acylated kaempferol glycosides (Fiorin C. et 
al., 1998), sesquiterpene lactones (Dall'Acqua et al. 2006), megastigmane glycosides (Marino et al., 
2004), (+)-catechin, (-)-epicatechin, (+)-gallocatechin, (+)-epigallocatechin and procyanidins (B2, B4, 
B5 and B7) (Sakar M. K. et al, 1985). The plant is one of the most widely used culinary spices in all 
Western countries.  Its leaves are traditionally used orally to treat the symptoms of gastrointestinal 
problems, such as epigastric bloating, impaired digestion, eructations and flatulence (Brunetton, 
1999). The aqueous extract is used in Turkish folk medicine as an anti-hemorrhoidal, anti-rheumatic, 
diuretic, as an antidote in snake bites and for the treatment of stomach-ache (Sezik E., 1999, Baytop 
T., 1984).  
A survey of the literature showed that no experimental data are available regarding its 
hepatoprotective potential. It was therefore, interesting to investigate, in the present study the possible 
hepatoprotective effect of L. nobilis leaves and to separate and identify some of their constitutive 
flavonoids. 
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Experimental: 
Plant Material: 
The leaves of L. nobilis were collected from a private farm in El- Mansouria area, Giza, Egypt, 
in September 2010 and authenticated by Dr. M. El Gebali, National Research Centre (NRC), Cairo , 
Egypt.  
Instruments and Materials: 
1H NMR spectra were measured by a Jeol ECA 500 MHz NMR spectrometer. 1H chemical 
shifts (δ) were measured in ppm, relative to TMS and 13C NMR chemical shifts relative to DMSO-d6 
and converted to TMS scale by adding 39.5. spectral width = 8 kHz for 1H and 30 kHz for 13C, 64 K 
data points and a flip angle of 45o. UV recording was made on a Shimadzu UV–Visible-1601 
spectrophotometer. Paper chromatographic analysis was carried out on Whatman No. 1 paper, using 
solvent systems: (1) H2O; (2) 6 % HOAc; (3) BAW (n-BuOH : HOAc : H2O, 4:1:5, upper layer). 
Solvent 3 was used for preparative paper chromatography (Prep. PC) using Whatman  No. 3 paper. 
In vitro Bioassay on Primary Culture of Rat Hepatocytes Monolayer: 
Isolation and Culture of Rat Hepatocytes Monolayer: 
Primary culture of rat hepatocytes was prepared according to (Seglen, 1976) method, modified 
by (Kiso, et al. 1983) using Wistar male rats (250-300 g) obtained from the animal house of the NRC 
(National Research Center, Cairo). Animal procedures were performed in accordance with the Ethics 
Committee of the National Research Centre and followed the recommendations of the National 
Institutes of Health Guide for Care and Use of Laboratory Animals (NIH Publication No. 85-23, 
revised 1985). At time of surgery, the rat was anesthesized by intra-peritoneal injection of 3.4mL/kg 
of sodium thiopental solution (0.1g/mL). A midline incision was made, the liver was exposed and the 
portal vein was cannulated with a needle fitted with a teflon catheter. After the teflon catheter was tied 
in place and the needle removed, the inferior vena cava was cut below the renal vein to allow blood 
drainage. Perfusion of the liver was started with Ca2+ free buffer (buffer 1), which contained HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (10 mmole/L), NaCl (137 mmole/L), KCl (2.68 
mmole/L), Na2HPO4 (0.7 mmole/L), D (+) glucose (10 mmole/L) and EGTA (ethylene glycol 
tetraacetic acid) (0.5 mmole/L), and adjusted to pH 7.45 at 37ºC. The flow-rate was 11.6 mL/min. The 
thoracic portion of the superior vena cava was cannulated, and the inferior vena cava was tied-off 
above the renal vein. After perfusing the liver for 15min., recirculation of Ca2+-containing buffer 
(buffer 2), containing additionally to buffer 1, CaCl2 (5mmole/L) and Collagenase type IV (10g/L) 
(pH 7.45 at 37ºC) was started, adjusted at a flow-rate of 7.5 mL/min, for 10 min. After perfusion with 
buffer 2, the liver was dissected out of the body, placed in a beaker containing buffer 2 and transferred 
under sterile conditions to laminar flow and gently dispersed with two forceps into small pieces (2-3 
mm). The cell suspension was then filtered through the cotton gauze into centrifuge tubes. Finally, the 
preparation was centrifuged at 600 rpm for 5 min. The supernatant was aspirated off and the loosely 
packed pellet of cells was gently re-suspended in Phosphate buffer (PB) (0.1 mole/L), which 
contained NaH2PO4 (0.2 mole/L) and Na2HPO4 (0.2 mole/L), adjusted at pH 7.6 at 37ºC, and then 
diluted two-folds with distilled water. This washing procedure was repeated twice. Viability of the 
cells to exclude the dye, trypan blue, was determined by incubating cell suspension (0.1 mL) with 
trypan blue (0.9 mL) and then counting the number of the cells that excluded the dye and the number 
of cells whose nuclei were stained blue, using haemocytometer under light microscope (Nikon). 
Complete culture medium was added over the total counted cells to reach a concentration of 1 x 106 
cells/mL. 
The culture medium was composed of RPMI-1640 medium, supplemented with 10% 
inactivated (56ºC for 30 min) fetal calf serum (FCS) (0.05/mL), penicillin-streptomycin (0.01/mL), 
insulin (0.7 (g/mL) and dexamethasone (4g/mL). Inocula of 1 x 106 cells/mL were seeded into plastic 
96-well plates and preincubated in CO2-Incubator at 37ºC, under 5% CO2 in air for 22-24 hrs. All 
buffers were freshly prepared and sterilized at 121ºC for 30 min. before use. 
IC50 Determination of the extract: 
After pre - incubation of primary culture of rat hepatocytes for 22-24 hrs, the monolayer was 
checked under inverted microscope (Olympus) for attachment. Then, the monolayer was washed 
twice with (Phosphate Buffer Saline (PBS), which contained KCl (2.68 mmole/L), Na2HPO4 (8.45 
mmole/L), KH2PO4 (1.5 mmole/L) and NaCl (137 mmole/L).  
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In order to determine IC50, different concentrations of the extract were prepared. The range of 
concentrations used started from 125 µg/mL followed by increasing concentrations in ascending order 
up to the concentration 1000 µg/mL that induced death of half the number of cells. L. nobilis extract 
was dissolved in dimethylsulfoxide (DMSO) (1% maximum concentration). For each concentration, 
three replicates were carried out. The plate was incubated for 2 hrs, in CO2 incubator. 
After cell incubation with the extract, cell viability was determined using neutral red assay 
(NR).  200 µL culture medium containing all except (PS), was added to each well together with 50 µL 
of a solution of 2 mg NR/mL PBS. After incubation for 3 hrs, supernatant was removed as previously 
described and the neutral red dye obtained was dissolved in 200 µL 50% ethanol with 1% acetic acid. 
The plate was then shaken for 5 min. on a microtitre plate shaker and the plate on Microelisa reader 
was read at 540 and 630 nm dual wavelength using automatic kinetic microplate reader (Labsystems 
Multiskan RC reader). 
 Evaluation of the effect of the extract on cultured hepatocytes was obtained by calculating the 
absorption of the cell viability with respect to control cells. Each experiment was carried out in 
triplicate to confirm validity of results. A graph was plotted with x-axis showing different 
concentrations of extract used, y-axis showing absorbance percentage of viable cells. IC50 was 
graphically determined from the concentration that yielded an absorption coinciding with 50% 
absorbance.  
Extraction, isolation and purification:  
The aqueous methanolic extract of L. nobilis leaves (48 g) showed by preliminary two-
dimensional paper chromatographic (2D-PC) screening to contain a complicated flavoniod mixture 
from which fourteen compounds (1-14) were isolated and purified through fractionation on polyamide 
6s (400 g) column (150 × 5 cm) and elution with H2O followed by H2O-MeOH mixtures of 
decreasing polarities to yield eight column fractions (I-VIII). The received fractions, were 
individually subjected to 2D-PC and other isolatory chromatographic techniques, thus yielding ten 
flavonoids (1, 4, 5-12) isolated from this plant for the first time.  
Isolation and purification of flavonoids from L. nobilis leaves. 
Compound 1 (87 mg) was purely isolated from fraction II (eluted with 10% aq. MeOH) by 
repeated column fractionation of 1.8 g material over Sephadex LH-20 using H2O for elution. 
Compound 2 (108.8 mg) was crystallized from an aqueous solution of 2.1 g of fraction III (eluted with 
20% aq. MeOH). Compound 3 (99 mg) was purely isolated from 1.1 g of fraction IV (eluted with 
30% aq. MeOH) by preparative PC, using BAW as solvent.  Compounds 4 (76 mg), 5 (115 mg) and 6 
(78.5 mg) were individually separated pure from a Sephadex LH-20 column of fraction V (2.2 g, 
eluted with 50% aq. MeOH), using n-butanol water saturated for elution. Compounds 7 (54 mg), 8 (71 
mg) and 9 (57 mg) were obtained pure from 1.93 g of fraction VI (eluted with 60% aq. MeOH) by 
applying Sephadex LH-20 column fractionation, using n-butanol water saturated for elution. 
Compound 10 (31 mg) and 11 (66 mg) were obtained from 3.1 g of fraction VII (eluted with 80% aq. 
MeOH). Compounds 12 (74 mg) and 13 (35 mg) and 14 (20mg) were isolated from 6.2 g of fraction 
VIII (eluted with 90% aq. MeOH) by repeated prep. PC using  6% AcOH and BAW as solvent. 
Spectral data of compounds (1, 4, 5-12) isolated for the first time from L.nobilis leaves.  
Quercetin 3-O- α-L-rhamnopyranoside (1) was obtained as pale yellow amorphous powder of Rf 
values (x 100):22 (H2O), 48 (AcOH-6), 68(BAW). It exhibited a Mr of 448 in negative ESI-MS 
analysis ([M-H]- at m/z = 447.1). UV spectral data λmax (MeOH): 259 nm, 297 nm sh., 348 nm, + 
NaOMe: 270 nm, 355nm, 402 nm, + NaOAC: 276 nm, 372 nm, + NaOAC + H3BO3: 272 nm, 383 nm, 
+Al Cl3: 268 nm, 352 nm, 408 nm. 1H- NMR spectral data (DMSO-d6) δ (ppm), quercetin moiety: 6.17 
(d, J=2.5 Hz, H-6), 6.36  (d, J=2.5 Hz, H-8), 7.25 (d, J=2.5, H-2’), 6.82 (d, J=8 Hz, H-5’), 7.25 (dd, 
J=2.5 and 8 Hz,  H-6’), rhamnose moiety: 5.20 (∆ν1/2 = 4 Hz, H-1”), 3.1 – 3.9 (m, overlapped with 
water  proton resonances, H-2”- H-5”), 0.77 (d, J= 6, H-6’’). 13C-NMR spectral data (DMSO-d6) δ 
(ppm), quercetin moiety: 156.9 (C-2), 134.6 (C-3), 178.2 (C-4), 161.7(C-5), 99.19 (C-6), 164.7 (C-7), 
94.15(C-8), 157.8 (C-9), 104.5 (C-10),121.2 (C-1’),115.9 (C-2’), 145.7 (C-3’),  148.9(C-4’), 116.1(C-
5’), 121.6 (C-6’), rhamnose moiety: 102.2 (C-1”), 70.8 (C-2”), 71.1 (C-3”), 71.6 (C-4”),  70.5 (C-5”), 
18.01(C-6’’). 
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Kaempferol 3-O- β- glucopyranoside (4): was obtained as pale yellow amorphous powder of Rf 
values (x 100): 24 (H2O), 47 (AcOH-6), 76 (BAW). It exhibited a Mr of 432 in negative ESI-MS 
analysis [M-H]- at m/z = 431. UV spectral data λmax (MeOH): 266 nm, 345 nm, + NaOMe: 271 nm, 
376nm, + NaOAC: 270 nm, 346 nm, + NaOAC + H3BO3: 270 nm, 346 nm sh., 405, +Al Cl3: 268 nm, 
340 nm sh., 385 nm. 1H- NMR spectral rata (DMSO-d6) δ (ppm), kaempferol moiety: 6.186 (d, J=2.5 
Hz,H-6), 6.38  (d, J=2.5 Hz,H-8), 7.7 (d, J=2.5, H-2’, H-6’), 6.89 (d, J=8 Hz, H- 3’,H-5’), glucose 
moiety: 5.26 (d, J=8 Hz, H-1’’), 3.4-4.0 (m, H-2’’- H-6’’). 13C-NMR spectral data (DMSO-d6) δ 
(ppm), kaempferol moiety: 158.6 (C-2), 133.6 (C-3), 179.9 (C-4), 162.5 (C-5), 100.9 (C-6), 167.0 (C-
7), 95.2 (C-8), 159.3 (C-9), 106.1 (C-10), 123.1 (C-1’), 132.6 (C-2’, C-6’), 116.3 (C-3’, C-5’), 162.1 
(C-4’), glucose moiety: 105.1 (C-1’’), 73.1 (C-2’’), 75.1 (C-3’’), 70.3 (C-4’’), 77.2 (C-5’’), 61.9 (C-
6’’). 
 
Quercetin 3'-O- β- glucopyranoside (5) was obtained as yellowish white amorphous powder of Rf 
values (x 100): 23 (H2O), 42 (AcOH-6), 53 (BAW). It showed a Mr of 464 in negative ESI-MS, 
corresponding to a molecular ion   [M-H]- at m/z = 463. UV Spectral Data λmax (MeOH): 255 nm, 266 
nm sh., 370 nm + NaOMe: 271 nm, 330 nm, 430 nm, + NaOAC: 260 nm sh., 272 nm, 320 nm, 340, + 
NaOAC + H3BO3  : 255 nm,  268 nm sh., 305 nm sh., 375 nm,  +Al Cl3 : 265 nm, 305 nm sh.,  360 nm 
, 430 nm. 1H- NMR Spectral Data (DMSO-d6) δ (ppm), quercetin moiety: 6.16 (d, J=2.5 Hz, H-6), 
6.6.4  (d, J=2.5 Hz, H-8), 6.86 (d, J = 8.0 Hz, H-5'), 7.45 (dd, J=2.5 and 7.5 Hz, H-6'), 7.85 (s, H- 2'), 
glucose moiety: 5.05 (d, J=8 Hz, H-1’’), 3.4-4.0 (m, H-2’’- H-6’’). 13C-NMR spectral data (DMSO-
d6) δ (ppm), quercetin moiety:147.4 (C-2), 137.47 (C-3), 177.36 (C-4), 162.53 (C-5), 99.3 (C-6), 
165.65 (C-7), 94.42 (C-8), 158.17 (C-9), 104.55 (C-10), 124.92 (C-1’), 115.86 (C-2’), 147.67 (C-3’), 
146.52 (C-4’), 116.97 (C-5’), 121.42 (C-6’),  glucose moiety: 105.1 (C-1’’), 73.1 (C-2’’), 75.1 (C-3’’), 
70.3 (C-4’’), 77.2 (C-5’’), 61.9 (C-6’’). 
 
Quercetin 3-O-β-galactoside (6) was obtained as yellowish white amorphous powder of Rf values (x 
100): 20 (H2O), 37 (AcOH-6), 56 (BAW). It showed a Mr of 464 in negative ESI-MS, corresponding 
to a molecular ion   [M-H]- at m/z = 463. UV spectral data λmax (MeOH): 257 nm, 266 nm sh., 359 nm, 
+ NaOMe: 266 nm, 227 nm sh., 408 nm, + NaOAC: 274 nm, 379 nm, + NaOAC + H3BO3: 268 nm, 
272 nm sh., 384 nm, +Al Cl3: 265 nm,   272 nm sh.,   384 nm. 1H- NMR spectral data (DMSO-d6) δ 
(ppm), quercetin moiety: 6.19 (d, J=2.5 Hz, H-6), 6.4 (d, J=2.5 Hz, H-8), 7.54 (d, J=2.5 Hz, H-2’), 
6.82 (d, J=8 Hz, H-5’), 7.65 (dd, J=2 and 8 Hz, H-6’), galactose moiety:  5.36 (d, J=8 Hz, H-1”), 3.2 – 
3.8 (m, H2”-6” ). 13C-NMR spectral data (DMSO-d6) δ (ppm), quercetin moiety:  156.24 (C-2), 
133.33 (C-3), 177.32 (C-4), 160.57 (C-5), 98.61(C-6), 164.79 (C-7), 93.57 (C-8), 156.26 (C-9), 
103.75 (C-10), 120.91(C-1’), 115.164 (C-2’), 144.89 (C-3’), 148.31 (C-4’), 115. 51  (C-5’), 121. 
81(C-6’), galactose moiety: 101.79 (C-1”), 71.074 (C-2”), 72.97 (C-3”), 67.81 (C-4”), 75.54 (C-5”), 
60 (C-6”). 
 
Isorhamnetin 3-O- β- glucopyranoside (7) was obtained as yellowish white amorphous powder of Rf 
values (x 100): 11 (H2O), 12 (AcOH-6), 52 (BAW). It showed a Mr of 478 in negative ESI-MS, 
corresponding to a molecular ion   [M-H]- at m/z = 477.3. UV spectral data λmax (MeOH): 256 nm, 300 
nm sh., 354 nm, + NaOMe : 275 nm, 325 nm sh., 408 nm, + NaOAC: 275 nm, 323 nm, 371 nm, + 
NaOAC + H3BO3  : 276 nm,  295 nm sh., 355 nm +Al Cl3 : 269 nm,   365 nm, 403 nm. 1H- NMR 
spectral data (DMSO-d6) δ (ppm), isorhamnetin moiety: 6.22  (d, J=1.6 Hz, H-6), 6.43 (d, J=1.6 Hz, 
H-8), 3.84(s, OCH3), 7.95 (d, J=1.6 Hz, H-2’), 6.93 (d, J=8.4 Hz, H-5’), 7.56 (dd, J=1.6 and 8.4 Hz, 
H-6’), glucose moiety: 5.57 (d, J=8 Hz, H- 1’’), 3.0-3.8 (m, H-2’’- H-6’’). 13C-NMR spectral data 
(DMSO-d6) δ (ppm), isorhamnetin moiety: 156.3 (C-2), 133.2 (C-3), 177.3 (C-4), 161.1 (C-5), 98.7 
(C-6), 164.3 (C-7), 93.6 (C-8), 156.2 (C-9), 103.9 (C-10), 55.6 (OCH3), 120.9 (C-1’), 113.4 (C-2’), 
148.4 (C-3’), 149.3 (C-4’), 115.1 (C-5’), 122.0 (C-6’), glucose: 100.8 (C-1”), 74.2 (C-2”), 76.3 (C-
3”), 70.4 (C-4”), 77.3 (C-5”), 60.5 (C-6”).  
 
Isorhamnetin 3-O- β- galactopyranoside (8) was obtained as yellowish white amorphous powder of 
Rf values (x 100): 11 (H2O), 12 (AcOH-6), 52 (BAW). It showed a Mr of 478 in negative ESI-MS, 
corresponding to a molecular ion   [M-H]- at m/z = 477.3. UV spectral data λmax (MeOH): 256 nm, 300 
nm sh., 354 nm, + NaOMe : 275 nm, 325 nm sh., 408 nm, + NaOAC: 275 nm, 323 nm, 371 nm, + 
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NaOAC + H3BO3  : 276 nm,  295 nm sh., 355 nm,  +Al Cl3 : 269 nm,   365 nm, 403 nm. 1H- NMR 
spectral data (DMSO-d6) δ (ppm), isorhamnetin moiety: 6.22  (d, J=1.6 Hz, H-6), 6.43 (d, J=1.6 Hz, 
H-8), 3.84(s, OCH3), 7.95 (d, J=1.6 Hz, H-2’), 6.93 (d, J=8.4 Hz, H-5’), 7.56 (dd, J=1.6 and 8.4 Hz, 
H-6’), galactose moiety: 5.36 (d, J=8 Hz, H- 1’’), 3.2 - 3.8 (m, H-2’’- H-6’’). 13C-NMR spectral data 
(DMSO-d6) δ (ppm), isorhamnetin moiety: 156.3 (C-2), 133.2 (C-3), 177.3 (C-4), 161.1 (C-5), 98.7 
(C-6), 164.3 (C-7), 93.6 (C-8), 156.2 (C-9), 103.9 (C-10), 55.6 (OCH3), 120.9 (C-1’), 113.4 (C-2’), 
148.4 (C-3’), 149.3 (C-4’), 115.1 (C-5’), 122.0 (C-6’), glalactose: 101.79 (C-1”), 71.07 (C-2”), 72.97 
(C-3”), 67.81 (C-4”), 75.54 (C-5”), 60.5(C-6”).  
 
Quercetin 3-O- rutinoside (9) was obtained as yellowish white amorphous powder of Rf values (x 
100): 48 (H2O), 44 (AcOH-6), 32 (BAW). It showed a Mr of 610 in negative ESI-MS, corresponding 
to a molecular ion   [M-H]- at m/z = 609.1. UV spectral data λmax (MeOH): 256 nm, 265 nm sh., 358 
nm+ NaOMe : 268 nm, 327 nm sh., 403 nm, + NaOAC: 273 nm, 323 nm, 387 nm, + NaOAC + 
H3BO3  : 262 nm,  377 nm, +Al Cl3 : 273 nm,   430 nm. 1H- NMR spectral data (DMSO-d6) δ (ppm), 
quercetin moiety: 6.0 (d, J=2.5 Hz, H-6), 6.2 (d, J=2.5 Hz, H-8), 7.4 (d, J=2.5 Hz, H-2’), 6.7 (d, J=8 
Hz, H-5’), 7.5(dd, J=2 and 8 Hz, H-6’), glucose moiety: 5.23 (1H, d, J = 7.5 Hz, H-1''), 3-3.8 (m, H-
2''- H- 6''), rhamnose moiety: 4.37 (s, H-1'''), 3-3.8 (m, H-2'''- H- 5'''), 1.10 (d, J = 6.0 Hz, H-6''') . 13C-
NMR  spectral data (DMSO-d6) δ (ppm), quercetin moiety: 156.9 (C-2), 133. 8 (C-3), 177.8 (C-4), 
161.7 (C-5), 98.7(C-6), 164.6 (C-7), 93.9 (C-8), 157.1 (C-9),  104.4 (C-10), 121.6 (C-1’), 115.7 (C-
2’), 145.3 (C-3’), 149.0 (C-4’), 116.7 (C-5’), 122.3(C-6’), glucose moiety: 101.2 (C-1’’), 74.59 (C-
2’’), 76.9 (C-3’’), 70.5 (C-4’’), 76.4 (C-5’’), 67.5 (C-6’’), rhamnose moiety: 101.7 (C-1’”), 70.8 (C-
2”’), 71.1 (C-3,’”), 72.36 (C-4’”),  68.7 (C-5’”), 18.4(C-6’’’). 
 
Kaempferol 3-O- rutinoside (10) was obtained as yellowish white amorphous powder of Rf values (x 
100): 49 (H2O), 47 (AcOH-6), 35 (BAW). It showed a Mr of 594 in negative ESI-MS, corresponding 
to a molecular ion   [M-H]- at m/z = 593.1. UV Spectral Data λmax (MeOH): 252 nm, 352 nm sh., + 
NaOMe : 273 nm, 324 nm sh., 395 nm, + NaOAC: 273 nm, 310 nm, 385 nm, + NaOAC + H3BO3  : 
266 nm,  355 nm, +AlCl3 : 272 nm,   392 nm. 1H- NMR Spectral Data (DMSO-d6) δ (ppm), 
kaempferol moiety: 6.18 (d, J=2.5 Hz, H-6), 6.44  (d, J=2.5 Hz, H-8), 7.92 (d, J=2.5 Hz, H-2’, H-6’), 
6.82 (d, J=8 Hz, H- 3’,H-5’), glucose moiety: 5.23 (d, J = 7.5 Hz, H-1''), 3-3.8 (m, H-2''- H- 6''), 
rhamnose moiety: 1.10 (1H, d, J = 6.0 Hz, H-6'''), 4.37 (s, H-1'''), 3-3.8 (m, H-2'''- H- 5'''). 13C-NMR 
Spectral Data (DMSO-d6) δ (ppm), kaempferol moiety: 157.4 (C-2), 133.7 (C-3), 178.2 (C-4), 161.5 
(C-5), 99.4 (C-6), 164.9 (C-7), 94.3 (C-8), 157.8 (C-9), 104.4 (C-10), 121.3 (C-1’), 131.7 (C-2’, C-6’), 
161.8 (C-4’), 115.8 (C-3’, C-5’), glucose moiety: 100.9 (C-1’’), 74.59 (C-2’’), 76.9 (C-3’’), 70.5 (C-
4’’), 76.4 (C-5’’), 67.5 (C-6’’), rhamnose moiety: 102.2 (C-1’”), 70.8 (C-2’’’), 71.1 (C-3’”), 71.6 (C-
4’”),  70.5 (C-5’”), 18.01(C-6’’’). 
 
Isorhamnetin-3-O-rutinoside (11) was obtained as yellowish white amorphous powder of Rf values 
(x 100): 22 (H2O), 39 (AcOH-6), 48 (BAW). It showed a Mr of 624 in negative ESI-MS, 
corresponding to a molecular ion   [M-H]- at m/z = 623. UV Spectral Data λmax (MeOH): 252 nm, 352 
nm sh., + NaOMe : 268 nm, 326 nm sh., 405 nm, + NaOAC: 269 nm, 322 nm, 360 nm, + NaOAC + 
H3BO3  : 252 nm,  353 nm sh., +Al Cl3 : 264 nm,   298 nm sh.,  355 nm. 1H- NMR Spectral Data 
(DMSO-d6) δ (ppm), isorhamnetin moiety: 3.97 (s, OCH3), 6.15 (d, J=2.5 Hz,H-6), 6.35  (d, J=2.5 
Hz,H-8), 6.93 (d, J = 8.0 Hz, H-5'), 7.5 (d, J = 8.0 Hz, H-6'), 7.85 (s, H- 2'),  glucose moiety: 5.4 (d, J 
= 7.5 Hz, H-1''), 3-3.8 (m, H-2''- H- 6''), rhamnose moiety: 4.53 (s, H-1'''), 3-3.8 (m, H-2'''- H- 5'''), 
1.10 (d, J = 6.0 Hz, H-6'''). 13C-NMR Spectral Data (DMSO-d6) δ (ppm), isorhamnetin moiety: 157.4 
(C-2), 134.3 (C-3), 161.9 (C-5), 98.9 (C-6), 165.1 (C-7), 93.8 (C-8), 157.7 (C-9), 104.5 (C-10), 122.7 
(C-1'), 113.4 (C-2'), 147.2 (C-3'), 55.6 (C-3'-OCH3), 149.6 (C-4'), 114.9 (C-5'), 121.8 (C- 6'), glucose 
moiety: 103.0 (C-1''), 74.7 (C-2''), 77.0 (C-3''), 70.4 (C-4''),76.2 (C-5''), 67.3 (C-6''), rhamnose moiety: 
101.3 (C-1'''), 70.8 (C-2'''), 70.9 (C-3'''), 72.7 (C-4'''), 68.6 (C-5'''), 16.7 (C-6''').  
 
Isorhamnetin (12) was obtained as yellowish white amorphous powder of Rf values (x 100): 0 (H2O), 
2 (AcOH-6), 73 (BAW). It showed a Mr of 316 in negative ESI-MS, corresponding to a molecular ion   
[M-H]- at m/z = 315. UV Spectral Data λmax (MeOH): 255 nm, 266 nm sh., 370 nm + NaOMe : 271 
nm, 330 nm, 430 nm, + NaOAC: 260 nm sh., 272 nm, 320 nm, 340,  + NaOAC + H3BO3  : 255 nm,  
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268 nm sh., 305 nm sh., 375 nm,  +Al3 Cl3 : 265 nm, 305 nm sh.,  360 nm , 430 nm. . 1H- NMR 
Spectral Data (DMSO-d6) δ (ppm): 3.85 (s, OCH3), 6.2 (d, J=2.5 Hz,H-6), 6.45  (d, J=2.5 Hz, H-8), 
6.95 (d, J = 8.0 Hz, H-5'), 7.5 (dd, J=2.5 & 7.5 Hz, H-6'), 7.85 (s, H- 2').  
 
Results and Discussion: 
Hepatotoxicity:  
The viability assay was applied with a broad range of concentrations of the studied extract of L. 
nobilis leaves (from 125-1000 µg/mL) on monolayer of rat hepatocytes. It revealed that the extract 
exerts no toxic effect on the monolayer hepatocyte layer, Table (1) and Figure (1). 
Table (1):   Hepatotoxicity of different concentrations of L. nobilis leaf extract. 
Sample No. Concentration µg/mL 
Absorbance at  (540 λmax) of 
Neutral red for Viable Cells Mean S.D 
L. nobilis 
leaves 
125 
0.436 
0.49 0.07 0.564 
0.466 
250 
0.479 
0.38 0.10 0.382 
0.277 
500 
0.307 
0.32 0.05 0.371 
0.275 
1000 
0.340 
0.28 0.07 0.196 
0.293 
Control 100% Viable cells 
0.604 
0.50 0.06 
0.502 
0.495 
0.438 
0.478 
0.496 
 
Figure (1): Viability of monolayer of rat hepatocytes after 2 hrs treatment with different 
concentrations of the Extract using NR Colourimetric Assay. Each point represents the Mean ± S.D 
(n=3). 
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Evaluation of Hepatoprotective Activity Applying Rat Hepatocyte Monolayer: 
The hepatoprotective effect of the tested extract against paracetamol toxic effect could be 
concluded from Table (2) and Figure (2). The L. nobilis leaves extract exhibited a hepatoprotective 
activity at 40 µg/ ml. 
 
Table (2): Hepatoprotection of different concentrations of L.nobilis leaves under Investigation. 
 
Sample No. Concentration µg/mL 
Absorbance at  (540 λmax) of 
Neutral red for Viable Cells Mean S.D 
L. nobilis 
leaves 
12.5 
0.371 
0.34 0.04 0.293 
0.360 
25 
0.380 
0.38 0.06 0.321 
0.443 
50 
0.513 
0.51 0.05 0.548 
0.457 
100 
0.667 
0.57 0.12 0.610 
0.443 
Control 
100% viable 
cells 
0.563 
0.54 0.03 0.556 
0.507 
Paracetamol           
20 mM 
0.363 
0.32 0.03 0.300 
0.309 
Silymarin                 
50 µg/mL 
0.582 
0.52 0.06 0.516 
0.470 
 
Figure (2): Viability of Monolayer of Rat Hepatocyte after 2 hrs Treatment with Different 
Concentrations of the Extract Followed by Treatment with 20 mM Paracetamol for 18 hrs. in 
comparison with 50 µg Silymarin as Control Using N.R Colourimetric Assay. Each Point Represents 
the Mean ± SD (n=3). 
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Identification and Structure Elucidation: 
Following column chromatographic fractionation of the L.nobilis leaf extract, 14 compounds 
(1–14) were isolated and identified using conventional and spectral analyses mainly NMR 
spectroscopy and mass spectrometry. 
Chromatographic behavior, UV spectral, ESI-MS (negative mode), 1H & 13C NMR data were 
consistent with those previously reported for, quercetin 3-O-α-rhamnopyranoside*1 (Babaei H. et al., 
2008), kaempferol 3-O-α- rhamnopyranoside 2 (Babaei H. et al., 2008), quercetin 3-O- β- 
glucopyranoside 3 (Kang et al., 2002), Kaempferol 3-O- β- glucopyranoside*4 (Makuch M. and 
Awska I., 2011), Quercetin 3'-O- glucoside*5 (Susan and Paul, 1984), quercetin 3-O- β- 
galactopyranoside*6 (Mahmoud et al. 2002) , isorhamnetin 3-O- β- glucopyranoside*7 (Olennikov et 
al. 2011), isorhamnetin 3-O- β- galactopyranoside*8 (Sikorska M. and Matlawska I., 2001), quercetin 
3-O- rutinoside*9 (Harborne J.B. 1994), kaempferol 3-O- rutinoside*10 (Brochado et al. 2003, 
Cardosa et al., 2005), isorhamnetin 3-O- rutinoside*11 (Harput et al., 2004), isorhamnetin*12 ( Cao 
X. et al.,2009),  quercetin 13 (Harborne, J.B., 1994) and kaempferol 14 (Smolarz, HD. , 2002). 
*Compounds isolated for the first time from L. nobilis leaves. 
 
Conclusion: 
L. nobilis leaves proved its capability on synthesizing and accumulating an appreciable number of 
flavonoid glycosides in its leaves. The extract of these leaves showed hepatoprotective activity against 
paracetamol toxic effects on rat hepatocytes at low concentration of 40 μg / ml. These findings require 
further investigation to isolate and identify the active compounds and to unravel the underlying 
mechanisms of action.  
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